PARSIPPANY, N.J., Nov. 6, 2026 /PRNewswire/ — Onkos Surgical, Inc. today announced a new FDA 510(k) clearance for its NanoCept® Antibacterial Technology, expanding its application to a broader offering of titanium components in the ELEOS™ Limb Salvage System. This marks another milestone in the company’s continued investment in antibacterial innovation.
ADDISON, Texas, Nov. 5, 2026 /PRNewswire/ — FX Shoulder Solutions, Inc. (FX), a global innovator dedicated exclusively to shoulder arthroplasty, announces a historic and revolutionary breakthrough in shoulder replacement technology with the FDA 510(k) clearance of Easytech Reversed® — the first-and-only FDA-cleared stemless reverse shoulder arthroplasty system in the United States and a game-changer in how surgeons can care for their patients.
Researchers led by Karan Ahuja built systems that recognize gestures and personalized activities, and the team is scaling up its work with Google partners
A team of engineers and surgeons from Johns Hopkins Medicine has published its first proof-of-concept study that shows temporarily implanting a tiny ultrasonic device into the location of a spinal cord injury can be feasible, safe and potentially useful.
Osseointegration is a reconstructive surgery for patients in which a prosthetic implant is connected directly to the bone.
Tibial stress fractures are among the most common overuse injuries affecting military personnel, but they can be difficult to identify in their earliest stages. Small stresses in the bone may develop before an injury becomes apparent through conventional diagnostic tools, creating a window of opportunity for earlier detection to enable intervention.
The FDA clearance permits the motion-preserving device to be implanted across two levels in the cervical spine.
Stryker (NYSE: SYK) earned an FDA 510(k) clearance for its latest ultrasonic bone and soft tissue removal platform, the Sonopet 3.
CORUS incorporates integrated screw fixation as a nonsegmental posterior instrumentation tool.
ALTSTÄTTEN, Switzerland and BOSTON, Oct. 6, 2026 /PRNewswire/ — icotec, the global leader in radiolucent implants for spine tumors and other complex spinal surgery patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for icotec’s spine implant system, CMORE® CT, effective October 1, 2026.